此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

通过增加家庭血压监测仪的使用率来改善中风患者的血压控制

2026年11月10日 更新者:Christina Mijalski、Stanford University

The goal of this clinical trial is to learn whether providing teaching with a low-cost device can help to improve blood pressure, health outcomes, patient self-efficacy without exacerbating inequity between advantaged and disadvantaged patients.

The main question[s] it aims to answer are:

  1. Does providing a free home blood pressure cuff improve control of hypertension?
  2. Does providing a free home blood pressure cuff have a greater impact on control of hypertension in disadvantaged populations?
  3. Does improved control of home blood pressure decrease adverse patient outcomes?

Participants will be asked to

  • Take their blood pressure at home and records the results
  • Participate in follow-up phone calls from investigators at at 3 and 6 months

Researchers will compare patients provided with home blood pressure monitors to those who are provided with routine education

研究概览

详细说明

Patients with a history of hypertension and a history stroke (ischemic or hemorrhagic), transient ischemic attack (TIA), or otherwise are at high risk of stroke will be screened for enrollment.

Inclusion and exclusion criteria will be reviewed and confirmed by a member of the study team. If the patient meets criteria, the following will occur:

A member of the study team (physician, nurse, study coordinator) will describe the study to the patient and inform them of their candidacy. If the patient indicates interest in study participation, the patient will be provided a written or electronic consent form to review and sign. The patient will be randomized to one of two arms in the study.

Upon enrollment, the patient will complete an intake survey. Prior to hospital discharge, patients randomized to arm 1 (control) of the study will receive routine stroke discharge education which is standard of care. In addition to standard of care, a stroke nurse will provide and review with the patient a short informational pamphlet (included in the attachments) on the importance of blood pressure monitoring.

Patients randomized to arm 2 (intervention) will also receive this teaching as above. In addition, they will be given an Omron Home Blood Pressure Cuff furnished by the study. The nurse will provide additional education on on how to use the cuff, and how to record values in a blood pressure log.

At three months following enrollment, a member of the study team will call the patients in both arms to complete a questionnaire (included in the attachments) over the phone and provide a blood pressure reading using their home blood pressure cuff. If needed, a phone interpreter will be used.

At three months, patients randomized to arm 1 of the study will receive a blood pressure cuff in the mail with written instructions on how to use it.

At six months following enrollment, a member of the study team will call the patients in both arms to complete a questionnaire over the phone and provide a blood pressure reading using their home blood pressure cuff. If needed, a phone interpreter will be used.

The patient will be notified that the duration of their participation in the study has ended. All study materials given to the patient are theirs to keep.

A chart review will be conducted for the study participants to supply information about health outcomes incurred throughout the duration of the study, and to obtain blood pressure readings from ambulatory visits.

研究类型

介入性

注册 (实际的)

37

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • Palo Alto、California、美国、94305
        • Stanford University Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients over the age of 18 admitted to the Stanford Hospital (SHC) stroke service and discharging to home or acute rehab
  • Diagnosis of Ischemic Stroke, Hemorrhagic Stroke, transient ischemic attack (TIA), or otherwise deemed to be at increased risk of stroke by the treating team (for example, asymptomatic carotid stenosis).
  • No usable home blood pressure cuff available
  • Diagnosis of hypertension or elevated blood pressure (> 130/80) concerning to the treating clinician for hypertension
  • Participant or surrogate able to apply a home blood pressure cuff on the participant
  • Patient or Legally Authorized Representative (LAR) agree to participate and are able to consent.

Exclusion Criteria:

  • Currently enrolled in another blood pressure or secondary prevention interventional research study
  • Upper arm circumference > 20 inches
  • Any other reason that, in the opinion of the investigator, makes the person a poor candidate for participation in this study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:交叉作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:Standard of Care

Participants will receive routine stroke discharge education which is standard of care. A stroke nurse will provide and review with the patient a short informational pamphlet on the importance of blood pressure monitoring.

实验性的:Access to Blood Pressure Monitoring

Participants will also receive the teaching administered to the control group. In addition, they will be given an Omron Home Blood Pressure Cuff furnished by the study. The nurse will provide additional education on on how to use the cuff, and how to record values in a blood pressure log.

Use of an Omron Home Blood Pressure Cuff to monitor blood pressure after discharge

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Blood pressure
大体时间:Month 3

Home blood pressure measurements provided by patient at month 3

Month 3
Blood pressure
大体时间:Month 6

Home blood pressure measurements provided by patient at month 6

Month 6

次要结果测量

结果测量
措施说明
大体时间
Incidence of stroke
大体时间:Months 3 and 6

Patient outcome

Months 3 and 6
Incidence of TIA
大体时间:Months 3 and 6

Patient outcome

Months 3 and 6
Any hospitalization
大体时间:Months 3 and 6

Patient outcome

Months 3 and 6

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Liron D Kraler, MD、Stanford University
  • 首席研究员:Christina M Mijalski Sells, MD、Stanford University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年5月1日

初级完成 (实际的)

2024年11月27日

研究完成 (实际的)

2025年4月30日

研究注册日期

首次提交

2023年1月27日

首先提交符合 QC 标准的

2023年2月14日

首次发布 (实际的)

2023年2月15日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月10日

最后验证

2024年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅